Zhenhua Chen

12PUBLICATIONS
41CO-AUTHORS
Molecular targetsMechanobiologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Feb 12, 2026
Targeting the C/EBPβ-PRAME-EZH2 complex modulates the Netrin-4/AKT axis to inhibit renal cancer tumorigenesis and metastasis.

Li-Zhen Zhang, Zheng-Kun Zhang, Liang-Min Fu

|Jul 31, 2025
MIAT promotes tumor-infiltrating CD8+ T-cell exhaustion and malignant progression of renal cell carcinoma via activating JAK3/STAT3 pathway.

Ming-Xiao Zhang, Lan-Yu Jing, Hao-Tian Tan

|Dec 13, 2024
Methionine-driven YTHDF1 expression facilitates bladder cancer progression by attenuating RIG-I-modulated immune responses and enhancing the eIF5B-PD-L1 axis.

Anze Yu, Liangmin Fu, Lanyu Jing

|Jul 08, 2024
Nuclear translocation of ISG15 regulated by PPP2R2B inhibits cisplatin resistance of bladder cancer.

Gaowei Huang, Jinwen Liu, Anze Yu

|Feb 21, 2024
PABPC1L Induces IDO1 to Promote Tryptophan Metabolism and Immune Suppression in Renal Cell Carcinoma.

Guannan Shu, Minyu Chen, Wuyuan Liao

|Oct 06, 2023
Bladder cancer intrinsic LRFN2 drives anticancer immunotherapy resistance by attenuating CD8+ T cell infiltration and functional transition.

Anze Yu, Jiao Hu, Liangmin Fu

Pageof 2

Frequent Collaborators

7 joint publications

Junhang Luo

4 joint publications

Liangmin Fu

3 joint publications

Jun Lu

3 joint publications

Yinghan Wang